Appointment booking for Dr. Richard Ingram, MD is currently not available.Dr. Richard Ingram, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Richard Ingram, MD (he/him) is a Oncologist in Winchester, VA with over 18 years of experience. What is your opinion of Dr. Richard Ingram, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Richard Ingram, MD has received over $7,476 which includes payments from the following companies:
$3,343.00 from Novocure Inc.
$2,477.40 from Onyx Pharmaceuticals, Inc., an Amgen subsidiary
$800.00 from Adaptive Biotechnologies Corporation
$174.83 from E.R. Squibb & Sons, L.L.C.
$142.58 from Genentech USA, Inc.
$101.55 from Amgen Inc.
$99.95 from sanofi-aventis U.S. LLC
$72.71 from Medivation Inc.
$57.45 from Novartis Pharmaceuticals Corporation
$50.49 from Janssen Biotech, Inc.
$38.74 from Pfizer Inc.
$26.45 from Helsinn Therapeutics (U.S.), Inc.
$25.87 from ASD Specialty Healthcare, INC.
$17.22 from ProStrakan, Inc.
$14.64 from Eisai Inc.
$11.63 from Lexicon Pharmaceuticals, Inc.
$11.58 from Merck Sharp & Dohme Corporation
$10.32 from Gilead Sciences Inc
Payments received by Dr. Richard Ingram, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!